Kelly Services-A
KELYA
15.95
+0.05
+0.31%
Kelly Services-A
US · KELYA
#3683 by market cap
15.95
+0.05
+0.31%
Live - 5344 symbols - heartbeat 14s ago
· 2026-10-08 10:22
After-hours
15.90
0.00%
- Market cap
- 553.97M
- P/E (TTM)i
- -2.06
- P/Bi
- 0.56
- EPSi
- -7.24
- Div yieldi
- 1.88%
- 52W posi
- 83%
Reader sentiment
Are you bullish or bearish on KELYA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.03, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -1.87% YoY
Margins
- Gross margin
- 20.07%
- Operating margin
- 0.64%
- Net margin
- -5.98%
Key ratios & quality
- Enterprise valuei
- 635.17M
- Altman Z-Scorei
- 3.03
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.51B | 5.36B | 4.52B | 4.91B | 4.97B | 4.84B | 4.33B | 4.25B |
| Gross profit | 972.20M | 968.40M | 827.60M | 919.20M | 1.01B | 961.40M | 882.60M | 853.00M |
| Selling & admin expenses | 884.80M | 883.10M | 805.60M | 870.60M | 943.50M | 934.70M | 818.40M | 825.90M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 87.40M | 85.30M | 22.00M | 48.60M | 68.30M | 26.70M | 64.20M | 27.10M |
| Pretax profit | -9.40M | 116.40M | -106.80M | 185.80M | -71.20M | 24.90M | -21.90M | -78.80M |
| Tax | -27.10M | 400.00K | -34.00M | 35.10M | -7.90M | -11.50M | -21.30M | 175.30M |
| Net profit | 22.90M | 112.40M | -72.00M | 156.10M | -62.50M | 36.40M | -600.00K | -254.10M |
| Basic EPS | 1 | 3 | -2 | 4 | -2 | 1 | 0 | -7 |
| Diluted EPS | 0.58 | 2.84 | -1.83 | 3.91 | -1.64 | 0.98 | -0.02 | -7.24 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.16B | 1.10B | 935.00M | 1.05B | 1.04B | 1.04B |
| Gross profit | 236.50M | 225.50M | 194.00M | 197.00M | 196.40M | 212.00M |
| Selling & admin expenses | 225.70M | 207.30M | 194.40M | 198.50M | 199.30M | 195.90M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 10.80M | 18.20M | -400.00K | -1.50M | -2.90M | 16.10M |
| Pretax profit | 7.60M | 19.90M | -103.70M | -2.60M | -6.70M | 14.40M |
| Tax | 1.80M | 900.00K | 46.40M | 126.20M | -800.00K | 3.00M |
| Net profit | 5.80M | 19.00M | -150.10M | -128.80M | -5.90M | 11.40M |
| Basic EPS | 0 | 1 | -4 | -4 | 0 | 0 |
| Diluted EPS | 0.16 | 0.52 | -4.26 | -3.69 | -0.17 | 0.31 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.40B | 1.41B | 1.55B | 1.59B | 1.72B | 1.63B | 1.37B | 1.27B |
| Cash & ST investments | 35.30M | 25.80M | 223.00M | 112.70M | 153.70M | 125.80M | 39.00M | 33.00M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 2.31B | 2.48B | 2.56B | 2.89B | 2.66B | 2.58B | 2.63B | 2.25B |
| Total current liabilities | 897.50M | 884.10M | 925.60M | 1.10B | 1.13B | 1.02B | 826.50M | 821.80M |
| Short-term debt | 2.20M | 22.00M | 19.90M | 17.50M | 15.40M | 8.40M | 12.30M | 12.30M |
| Long-term debt | -- | -- | -- | -- | -- | -- | 239.40M | 101.90M |
| Total liabilities | 1,154,900,000.00 | 1,216,100,000.00 | 1,358,900,000.00 | 1,558,000,000.00 | 1,409,600,000.00 | 1,327,900,000.00 | 1,397,700,000.00 | 1,274,100,000.00 |
| Total equity | 1.16B | 1.26B | 1.20B | 1.34B | 1.25B | 1.25B | 1.23B | 976.50M |
| Retained earnings | 1.14B | 1.24B | 1.16B | 1.32B | 1.22B | 1.24B | 1.23B | 965.10M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.35B | 1.25B | 1.28B | 1.27B | 1.30B | 1.30B |
| Cash & ST investments | 28.20M | 18.00M | 30.10M | 33.00M | 25.60M | 24.20M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 2.59B | 2.51B | 2.39B | 2.25B | 2.26B | 2.28B |
| Total current liabilities | 822.90M | 826.70M | 806.50M | 821.80M | 818.60M | 866.60M |
| Short-term debt | 12.20M | 12.10M | 12.30M | 12.30M | 11.40M | 10.80M |
| Long-term debt | 204.60M | 74.30M | 118.40M | 101.90M | 130.50M | 78.10M |
| Total liabilities | 1,354,400,000.00 | 1,245,800,000.00 | 1,278,000,000.00 | 1,274,100,000.00 | 1,286,500,000.00 | 1,298,700,000.00 |
| Total equity | 1.24B | 1.27B | 1.12B | 976.50M | 968.50M | 982.00M |
| Retained earnings | 1.23B | 1.25B | 1.10B | 965.10M | 956.50M | 965.10M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 61.40M | 102.20M | 186.00M | 85.00M | -76.30M | 76.70M | 26.90M | 122.60M |
| Depreciation & amortization | 26.20M | 53.90M | 45.30M | 51.00M | 51.90M | 50.10M | 50.90M | 53.30M |
| Free cash flow | 35.80M | 82.20M | 170.50M | 73.80M | -88.30M | 61.40M | 15.80M | 114.10M |
| Dividends paid | -11.80M | -11.90M | -3.00M | -4.00M | -10.60M | -11.00M | -10.90M | -11.00M |
| Stock buybacks / issuance | -- | -- | -- | 0 | -35.00M | -42.20M | -10.00M | -10.00M |
| Ending cash balance | 40.10M | 31.00M | 228.10M | 119.50M | 162.40M | 167.60M | 45.60M | 37.70M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 23.90M | 95.40M | -25.30M | 28.60M | -25.40M | 49.20M |
| Depreciation & amortization | 13.60M | 13.30M | 13.20M | 13.20M | 12.50M | 12.40M |
| Free cash flow | 21.40M | 93.40M | -27.60M | 26.90M | -26.50M | 47.70M |
| Dividends paid | -2.80M | -2.70M | -2.80M | -2.70M | -2.70M | -2.80M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 34.50M | 24.50M | 35.40M | 37.70M | 29.50M | 28.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 1.96 | 9.18 | -5.84 | 12.18 | -4.83 | 2.85 | -0.05 | -22.98 |
| ROA %i | 0.97 | 4.64 | -2.86 | 5.67 | -2.25 | 1.36 | -0.02 | -10.41 |
| ROIC %i | 2.10 | 9.03 | -5.37 | 11.57 | -4.58 | 2.50 | 0.19 | -18.50 |
| 5-year avg ROE %i | 5.94 | 7.22 | 4.84 | 4.80 | 2.53 | 2.71 | 0.86 | -2.57 |
| EBIT margin %i | -0.11 | 2.25 | -2.30 | 3.84 | -1.39 | 0.58 | -0.25 | -1.56 |
| FCF / sales %i | 0.65 | 1.53 | 3.78 | 1.50 | -- | 1.27 | 0.36 | 2.68 |
| Current ratioi | 1.56 | 1.59 | 1.67 | 1.45 | 1.52 | 1.59 | 1.65 | 1.54 |
| Quick ratioi | 1.48 | 1.48 | 1.61 | 1.40 | 1.46 | 1.26 | 1.57 | 1.49 |
| Debt / assetsi | 0.10 | 2.63 | 3.41 | 2.73 | 2.64 | 1.99 | 11.50 | 7.07 |
| LT debt / equityi | -- | 3.42 | 5.61 | 4.60 | 4.39 | 3.42 | 23.51 | 15.03 |
| Interest coveragei | -2.03 | 28.71 | -34.60 | 75.32 | -32.90 | 8.78 | -1.01 | -5.35 |
| Revenue CAGR (3Y) %i | -0.03 | 0.50 | -5.64 | -3.79 | -2.49 | 2.31 | -4.09 | -5.05 |
| Net income CAGR (3Y) %i | -24.78 | -2.37 | -- | 89.61 | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | 62.13 | 44.23 | 54.54 | 27.27 | -- | -28.85 | -40.18 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -1.60 | -0.49 | -13.04 | -22.98 | -24.05 | -24.28 |
| ROA %i | -0.81 | -0.25 | -6.15 | -10.41 | -10.95 | -11.39 |
| ROIC %i | -0.89 | 0.24 | -10.32 | -18.50 | -19.66 | -21.45 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -0.67 | -0.31 | -2.69 | -1.56 | -2.00 | -2.21 |
| FCF / sales %i | 1.49 | 2.34 | 2.28 | 2.68 | 1.60 | 0.50 |
| Current ratioi | 1.64 | 1.52 | 1.59 | 1.54 | 1.59 | 1.50 |
| Quick ratioi | 1.55 | 1.45 | 1.52 | 1.49 | 1.52 | 1.44 |
| Debt / assetsi | 10.25 | 5.33 | 7.41 | 7.07 | 8.16 | 5.64 |
| LT debt / equityi | 20.47 | 9.62 | 14.81 | 15.03 | 17.81 | 12.01 |
| Interest coveragei | -2.06 | -0.89 | -8.62 | -5.35 | -7.95 | -9.96 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Enterprise Talent Management (ETM) is the largest reported line at 46.76% of revenue, across 4 reported segments.
- Science, Engineering & Technology (SET) follows at 29.05%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Enterprise Talent Management (ETM)46.76%
Science, Engineering & Technology (SET)29.05%
Education24.42%
Quote time 2026-10-08 10:22:34 · For reference only, not investment advice and not tailored to your situation.